The PARAGON-HF trial : missed opportunity or first personalized therapy?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:21 |
|---|---|
| Enthalten in: |
Giornale italiano di cardiologia (2006) - 21(2020), 2 vom: 12. Feb., Seite 93-95 |
| Sprache: |
Italienisch |
|---|
| Weiterer Titel: |
Lo studio PARAGON-HF: opportunità mancata o prima terapia personalizzata? |
|---|
| Beteiligte Personen: |
Senni, Michele [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
80M03YXJ7I |
|---|
| Anmerkungen: |
Date Completed 16.02.2021 Date Revised 04.12.2021 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1714/3300.32700 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM306459140 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM306459140 | ||
| 003 | DE-627 | ||
| 005 | 20231225123418.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||ita c | ||
| 024 | 7 | |a 10.1714/3300.32700 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1021.xml |
| 035 | |a (DE-627)NLM306459140 | ||
| 035 | |a (NLM)32051630 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a ita | ||
| 100 | 1 | |a Senni, Michele |e verfasserin |4 aut | |
| 245 | 1 | 4 | |a The PARAGON-HF trial |b missed opportunity or first personalized therapy? |
| 246 | 3 | 3 | |a Lo studio PARAGON-HF: opportunità mancata o prima terapia personalizzata? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 16.02.2021 | ||
| 500 | |a Date Revised 04.12.2021 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Aminobutyrates |2 NLM | |
| 650 | 7 | |a Angiotensin Receptor Antagonists |2 NLM | |
| 650 | 7 | |a Biphenyl Compounds |2 NLM | |
| 650 | 7 | |a Drug Combinations |2 NLM | |
| 650 | 7 | |a Tetrazoles |2 NLM | |
| 650 | 7 | |a Valsartan |2 NLM | |
| 650 | 7 | |a 80M03YXJ7I |2 NLM | |
| 650 | 7 | |a sacubitril and valsartan sodium hydrate drug combination |2 NLM | |
| 650 | 7 | |a WB8FT61183 |2 NLM | |
| 700 | 1 | |a Di Tano, Giuseppe |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Giornale italiano di cardiologia (2006) |d 2006 |g 21(2020), 2 vom: 12. Feb., Seite 93-95 |w (DE-627)NLM16119561X |x 1972-6481 |7 nnns |
| 773 | 1 | 8 | |g volume:21 |g year:2020 |g number:2 |g day:12 |g month:02 |g pages:93-95 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1714/3300.32700 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 21 |j 2020 |e 2 |b 12 |c 02 |h 93-95 | ||